共 134 条
[1]
Jemal A(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
[2]
Siegel R(1986)Renal cell carcinoma: survival and prognostic factors Urology 27 291-301
[3]
Ward E(1993)Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up J Clin Oncol 11 1368-1375
[4]
Hao Y(2000)Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma Cancer J Sci Am 6 S55-57
[5]
Xu J(1987)Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study J Urol 138 1379-1381
[6]
Thun MJ(1997)Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group Int J Urol 4 8-12
[7]
Golimbu M(2003)Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial J Clin Oncol 21 1214-1222
[8]
Joshi P(2005)Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) Br J Cancer 92 843-846
[9]
Sperber A(1998)Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815-2834
[10]
Tessler A(2007)Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 16-188